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Vascularization holds the gold key for the effective survival and engraftment of complex 
engineered tissues and organs for Tissue Engineering and Regenerative Medicine. The lack of 
adequate vascularization post-transplantation often results in cell necrosis and ultimate failure 
and rejection of the engineered construct. Herein, we propose a strategy capable of surpassing 
this obstacle. Harnessing easy accessible adipose tissue stromal vascular fraction (SVF) as a 
source for cells with intrinsic angiogenic potential, and cell sheet technology we were able to 
engineer cell sheets with high angiogenic potential. SVF was isolated from the adipose tissue of 
healthy human subjects after enzymatic digestion and 2x10
5
 nucleated cells/well were seeded on 
24 well plates for cell sheet formation.  To further boost cells’ angiogenic potential, hypoxic 
conditions of 5% of oxygen were provided to some of the cells while the rest was cultured in 
typical normoxia, for up to 8 days of culture, in basal medium. Flow cytometry analysis 
demonstrated the presence of a heterogeneous population of mesenchymal progenitors, 
endothelial and hematopoietic cells. Furthermore, the proliferation of SVF cells was evaluated 
through dsDNA quantification, which showed higher numbers for cells in hypoxic conditions, at 
earlier time points. Immunocytochemistry against CD31 and CD146 revealed the presence of an 
interconnected and highly branched network of vessel-like structures, more prominent for cells 
in hypoxia after 5 days of culture and quite similar for both conditions after 8 days, in the 
absence of any specific media supplementation. In vivo testing using the cell sheets detached 
from the wells and HIF expression analysis are currently underway. Taken together, the great 
potentiality of cell sheet technology with SVF cells cultured in hypoxia opens new exciting 
perspectives and may represent tremendously valuable vascularization units for tissue 
engineering strategies. 
 
